S12.2 Type I interferons and their autoantibodies in the context of systemic lupus erythematosus
S12.2 Type I interferons and their autoantibodies in the context of systemic lupus erythematosus
About this item
Full title
Author / Creator
Haljasmägi, L , Bradford, H , Menon, M , Peterson, P , Vanker, M , Wincup, C , Bondet, V , Duffy, D , Isenberg, D , Kisand, K and Mauri, C
Publisher
London: Lupus Foundation of America
Journal title
Language
English
Formats
Publication information
Publisher
London: Lupus Foundation of America
Subjects
More information
Scope and Contents
Contents
PurposeType I IFNs and their autoantibodies are implicated in the pathogenesis of Systemic lupus erythematosus (SLE), but their incidence and importance is still unclear. Neutralizing autoantibodies against IFNα have been previously reported in patients with autoimmune polyendocrinopathy syndrome type I (APS-1), rheumatoid arthritis, thymoma and mo...
Alternative Titles
Full title
S12.2 Type I interferons and their autoantibodies in the context of systemic lupus erythematosus
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_c69aa1d852d348f995c9a81e0056f3d6
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c69aa1d852d348f995c9a81e0056f3d6
Other Identifiers
E-ISSN
2053-8790
DOI
10.1136/lupus-2022-elm2022.26
